Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00107 | 35217817 | Acta Pharmacol Sin | Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease. | 2022 | Details |
A00108 | 35217669 | Nat Commun | The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. | 2022 | Details |
A00109 | 35217283 | Clin Imaging | Ultrasound attenuation coefficient of the liver and spleen in adults: A preliminary observation. | 2022 | Details |
A00110 | 35217259 | J Pharm Biomed Anal | CE with Cu2+ ions and 2-hydroxypropyl-β-cyclodextrin additives for the investigation of amino acids composition of the culture medium in a cellular model of non-alcoholic fatty liver disease. | 2022 | Details |
A00111 | 35216753 | Lancet Digit Health | Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. | 2022 | Details |
A00112 | 35216556 | BMC Endocr Disord | Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease. | 2022 | Details |
A00113 | 35216439 | Int J Mol Sci | Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr-/-.Leiden Mice. | 2022 | Details |
A00114 | 35216326 | Int J Mol Sci | New Insights in the Control of Fat Homeostasis: The Role of Neurotensin. | 2022 | Details |
A00115 | 35216174 | Int J Mol Sci | Whole Body Ip6k1 Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction. | 2022 | Details |
A00116 | 35216100 | Int J Mol Sci | Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress. | 2022 | Details |
A00117 | 35215517 | Nutrients | Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases. | 2022 | Details |
A00118 | 35215504 | Nutrients | Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. | 2022 | Details |
A00119 | 35213373 | J Alzheimers Dis | Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study. | 2022 | Details |
A00120 | 35213006 | Methods Mol Biol | Generation of Adenovirus for In Vitro and In Vivo Studies of Hepatocytes. | 2022 | Details |
A00121 | 35213002 | Methods Mol Biol | Analysis of the Sphingolipidome in NAFLD. | 2022 | Details |
A00122 | 35213001 | Methods Mol Biol | In Vivo Analysis of Necrosis and Ferroptosis in Nonalcoholic Steatohepatitis (NASH). | 2022 | Details |
A00123 | 35213000 | Methods Mol Biol | Ex Vivo Dual-Hit Method for Inflammasome Activation in Liver. | 2022 | Details |
A00124 | 35212999 | Methods Mol Biol | Assessment of Lipotoxic Endoplasmic Reticulum (ER) Stress in Nonalcoholic Steatohepatitis (NASH). | 2022 | Details |
A00125 | 35212998 | Methods Mol Biol | Analysis of Insulin Resistance in Nonalcoholic Steatohepatitis. | 2022 | Details |
A00126 | 35212997 | Methods Mol Biol | Metabolic Phenotyping in Mice with NASH Using Indirect Calorimetry. | 2022 | Details |
A00127 | 35212996 | Methods Mol Biol | Computational Pipeline for Next-Generation Sequencing (NGS) Studies in Genetics of NASH. | 2022 | Details |
A00128 | 35212995 | Methods Mol Biol | Single Cell RNA Sequencing in NASH. | 2022 | Details |
A00129 | 35212994 | Methods Mol Biol | Analysis of Liver Responses to Non-alcoholic Steatohepatitis by mRNA-Sequencing. | 2022 | Details |
A00130 | 35212993 | Methods Mol Biol | Chromatin Immunoprecipitation Assay in Primary Mouse Hepatocytes and Mouse Liver. | 2022 | Details |
A00131 | 35212991 | Methods Mol Biol | Culture of Mouse Liver Ductal Organoids. | 2022 | Details |
A00132 | 35212989 | Methods Mol Biol | Purification and Isolation of Hepatic Stellate Cells. | 2022 | Details |
A00133 | 35212987 | Methods Mol Biol | Isolation and Culture of Mouse Hepatocytes and Kupffer Cells (KCs). | 2022 | Details |
A00134 | 35212986 | Methods Mol Biol | Measurement of In Vivo VLDL and Chylomicron Secretion. | 2022 | Details |
A00135 | 35212985 | Methods Mol Biol | Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH). | 2022 | Details |
A00136 | 35212984 | Methods Mol Biol | Measurement of Hepatic Lipids. | 2022 | Details |
A00137 | 35212983 | Methods Mol Biol | Hydrodynamic Injection for Developing NASH Model. | 2022 | Details |
A00138 | 35212982 | Methods Mol Biol | Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00139 | 35212981 | Methods Mol Biol | Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH). | 2022 | Details |
A00140 | 35212643 | Eur J Endocrinol | Increased liver fat associates with severe metabolic perturbations in low birth weight men. | 2022 | Details |
A00141 | 35212227 | J Agric Food Chem | Targeted Lipidomics Reveal the Effects of Different Phospholipids on the Phospholipid Profiles of Hepatic Mitochondria and Endoplasmic Reticulum in High-Fat/High-Fructose-Diet-Induced Nonalcoholic Fatty Liver Disease Mice. | 2022 | Details |
A00142 | 35212074 | J Magn Reson Imaging | Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine-Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00143 | 35211584 | World J Clin Cases | Nonalcoholic fatty liver disease shows significant sex dimorphism. | 2022 | Details |
A00144 | 35209867 | BMC Gastroenterol | Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China. | 2022 | Details |
A00145 | 35208613 | Medicina (Kaunas) | Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. | 2022 | Details |
A00146 | 35208576 | Medicina (Kaunas) | The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. | 2022 | Details |
A00147 | 35208513 | Medicina (Kaunas) | Evaluation of Dose-Dependent Obesity and Diabetes-Related Complications of Water Chestnut (Fruit of Trapa japonica) Extracts in Type II Obese Diabetic Mice Induced by 45% Kcal High-Fat Diet. | 2022 | Details |
A00148 | 35208265 | Metabolites | Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis. | 2022 | Details |
A00149 | 35208241 | Metabolites | Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases. | 2022 | Details |
A00150 | 35208229 | Metabolites | The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents. | 2022 | Details |
A00151 | 35208205 | Metabolites | A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver. | 2022 | Details |
A00152 | 35207770 | J Pers Med | Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients. | 2022 | Details |
A00153 | 35207239 | J Clin Med | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes. | 2022 | Details |
A00154 | 35207209 | J Clin Med | Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults. | 2022 | Details |
A00155 | 35206988 | Healthcare (Basel) | Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis. | 2022 | Details |
A00156 | 35206539 | Int J Environ Res Public Health | Protective Effect of Leisure-Time Physical Activity and Resistance Training on Nonalcoholic Fatty Liver Disease: A Nationwide Cross-Sectional Study. | 2022 | Details |
A00157 | 35204710 | Biomolecules | Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases. | 2022 | Details |
A00158 | 35204522 | Diagnostics (Basel) | A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer. | 2022 | Details |
A00159 | 35204498 | Diagnostics (Basel) | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. | 2022 | Details |
A00160 | 35204232 | Antioxidants (Basel) | Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway. | 2022 | Details |
A00161 | 35204113 | Antioxidants (Basel) | Effects of Colchicine in a Rat Model of Diet-Induced Hyperlipidemia. | 2022 | Details |
A00162 | 35203687 | Biomedicines | A Novel 2-Hit Zebrafish Model to Study Early Pathogenesis of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
A00163 | 35203662 | Biomedicines | The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. | 2022 | Details |
A00164 | 35203659 | Biomedicines | Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00165 | 35203610 | Biomedicines | Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study. | 2022 | Details |
A00166 | 35203502 | Biomedicines | Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model. | 2022 | Details |
A00167 | 35203484 | Biomedicines | Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. | 2022 | Details |
A00168 | 35203457 | Biomedicines | Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. | 2022 | Details |
A00170 | 35202771 | Diabetes Res Clin Pract | Dapagliflozin for nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
A00172 | 35201574 | Hepatol Int | Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis. | 2022 | Details |
A00173 | 35199429 | HIV Med | "Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV". | 2022 | Details |
A00174 | 35198905 | iScience | Deletion of RNF186 expression suppresses diet-induced hepatic steatosis by regulating insulin activity. | 2022 | Details |
A00175 | 35198900 | iScience | NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice. | 2022 | Details |
A00176 | 35197660 | Acta Inform Med | Biochemical Parameters as Predictors of Underlying Liver Disease in Patients with Chronic Kidney Disorders. | 2021 | Details |
A00177 | 35197460 | Nat Commun | Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice. | 2022 | Details |
A00178 | 35196551 | Ann Hepatol | Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease. | 2022 | Details |
A00179 | 35196511 | Am J Med Sci | Deciphering the Role of Aquaporins in Metabolic Diseases: A Mini Review. | 2022 | Details |
A00180 | 35196341 | PLoS One | The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy. | 2022 | Details |
A00181 | 35195774 | Arch Microbiol | A review on the effect of gut microbiota on metabolic diseases. | 2022 | Details |
A00182 | 35195697 | JAMA Netw Open | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00183 | 35195377 | Minerva Endocrinol (Torino) | Inflammation is associated with impairment of oxidative status, carbohydrate and lipid metabolism in type 2 diabetes complicated by non-alcoholic fatty liver disease. | 2022 | Details |
A00185 | 35194014 | Nutr Diabetes | Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity. | 2022 | Details |
A00186 | 35193993 | Gut Liver | Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2022 | Details |
A00187 | 35193889 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages-prospective study in Rajarata Pregnancy Cohort (RaPCo). | 2022 | Details |
A00188 | 35192934 | Mol Ther | Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2022 | Details |
A00189 | 35192912 | Diabetes Res Clin Pract | Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. | 2022 | Details |
A00190 | 35192675 | PLoS One | Itemization difference of patient-reported outcome in patients with chronic liver disease. | 2022 | Details |
A00191 | 35192111 | Clin Exp Med | Liver biopsy for assessment of chronic liver diseases: a synopsis. | 2022 | Details |
A00192 | 35191422 | Chin Med J (Engl) | Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease. | 2022 | Details |
A00193 | 35191421 | Chin Med J (Engl) | From MAFLD to hepatocellular carcinoma and everything in between. | 2022 | Details |
A00194 | 35190927 | Mol Biol Rep | Atheroprotective and hepatoprotective effects of trans-chalcone through modification of eNOS/AMPK/KLF-2 pathway and regulation of COX-2, Ang-II, and PDGF mRNA expression in NMRI mice fed HCD. | 2022 | Details |
A00195 | 35190696 | Acta Pharmacol Sin | Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. | 2022 | Details |
A00196 | 35190444 | BMJ Open | Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study. | 2022 | Details |
A00197 | 35190357 | Anatol J Cardiol | Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men. | 2022 | Details |
A00198 | 35189786 | Scand J Gastroenterol | Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. | 2022 | Details |
A00199 | 35189388 | Clin Gastroenterol Hepatol | Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium. | 2022 | Details |
A00201 | 35188871 | Epigenetics | Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children. | 2022 | Details |
A00202 | 35188038 | Scand J Gastroenterol | Non-alcoholic fatty liver disease and intestinal immune status: a narrative review. | 2022 | Details |
A00203 | 35187967 | Exp Biol Med (Maywood) | Iron-accumulating splenocytes may exacerbate non-alcoholic steatohepatitis through the production of proinflammatory cytokines and reactive oxygen species. | 2022 | Details |
A00204 | 35187942 | Rev Esp Enferm Dig | Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease. | 2022 | Details |
A00205 | 35187676 | J Food Biochem | Chitosan oligosaccharide attenuates hepatic steatosis in HepG2 cells via the activation of AMP-activated protein kinase. | 2022 | Details |
A00206 | 35187020 | Front Nutr | Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States. | 2022 | Details |
A00207 | 35186807 | Can J Gastroenterol Hepatol | Therapeutic Effects of Milk Thistle (Silybum marianum L.) and Artichoke (Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats. | 2022 | Details |
A00208 | 35185803 | Front Endocrinol (Lausanne) | Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
A00209 | 35185113 | J Pediatr Gastroenterol Nutr | Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study. | 2022 | Details |
A00210 | 35184490 | Zhonghua Liu Xing Bing Xue Za Zhi | [A cohort study on the correlation between alanine aminotransferase trajectories and new-onset metabolic fatty liver disease]. | 2022 | Details |